4 European Projects Found
Searched on 125080 European Projects
FINISHED
Combatting Bacterial Resistance in Europe (COMBACTE-NET)
Start date: Jan 1, 2013, End date: Dec 31, 2019,
... by the US and EU presidencies. The estimated costs of ARB are around € 1.5 Billion per year in Europe, with an estimated 25,000 deaths (European Center for Disease prevention and Control/European Medicines Agency “time to react”). While the threat of antimicrobial resistance is growing, so are the challenges to bringing forward new therapeutic options for patients infected with resistant organis ...
Read Project
38
Partners Participants
FINISHED
Incorporating real-life clinical data into drug development (GETREAL)
Start date: Oct 1, 2013, End date: Dec 31, 2016,
...it is accompanied by an extensive data package that provides information about the safety and efficacy of the medicine in a clinical trial setting. However, assessing the expected future value of the medicines when used in “real world” clinical practice requires additional information next to traditional (pre-authorisation) clinical trials. Regulatory, HTA agencies and other healthcare decision m ...
Read Project
32
Partners Participants
FINISHED
European programme in Pharmacovigilance and Pharmacoepidemiology (EU2P)
Start date: Sep 1, 2009, End date: Jun 30, 2016,
...onomous University of Barcelona, the Erasmus University Medical Center, the University of Utrecht, the University of Hert[ordshire, the University of Verona, the Karolinska Institute and the European Medicines Agency. It will deliver programmes in harmacovigilance and Pharmacoepidemiology for continuing education diploma, Master’s degree as well as PhD and a short course orientated towards risk co ...
Read Project
24
Partners Participants
FINISHED
Pharmacoepidemiolocal Research on Outcomes of Therapeutics by a European ConsorTium (PROTECT)
Start date: Sep 1, 2009, End date: Apr 30, 2015,
...rts and conflicting results from pharmacoepidemiology studies may lead to delay in, or inappropriate, regulatory decisions. The PROTECT consortium, consisting of 20 core partners lead by the European Medicines Agency (EMEA), willdevelop and test methods of proactive monitoring of drug safety and benefit risk (B/R) assessment utilising a large range of EU data sources and expertise. in partnership ...
Read Project
